TOGARAM2 and cervical carcinoma: Taken together, our data demonstrate that TOGARAM2 mediates aspects of the oncogenic functions of TAZ, particularly associated with cell migration and invasion and suggests that TOGARAM2 is a potential oncogene in HPV18+ cervical cancer cells.